Other DLL3 Expressing epNEC
1 clinical trials · Condition
◉ Watch Other DLL3 Expressing epNEC
| Record | Firm | Date |
|---|---|---|
| Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors (NCT07278479) | Molecular Partners AG | 2026-05-18 |
Track Other DLL3 Expressing epNEC automatically
Every clearance here is in the API, with alerts when new ones post.